This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Reviewing the potential of Pfizers etrasimod for ulcerative colitis

Ticker(s): PFE

Who's the expert?

Dr. Andrew Ukleja is an Assistant Professor of Medicine at Harvard Medical School, and works as a Gastroenterologist at Beth Israel Deaconess Medical Center (BIDMC) and BI-Milton Hospital. He also serves as a Director of Community Endoscopy for BIDMC. He finished his fellowship in Gastroenterology at Mayo Clinic Jacksonville, Florida.  He previously worked at Cleveland Clinic Florida for 17 years, serving as a Director of the Nutrition Support Team and also running a small Intestinal Failure Program.  He is a past President of Florida Society for Parenteral and Enteral Nutrition.  He also has held leadership positions in the American Society for Parenteral and Enteral Nutrition. He held an appointment as a Clinical Affiliate Associate Professor of Medicine at St. George’s University, School of Medicine. His special areas of interest include: enteral and parenteral nutrition, intestinal failure, and gastrointestinal dysmotility. Dr. Ukleja has developed national and international reputation based on his expertise in nutrition support, intestinal failure, gastric dysmotility and bariatric surgery complications.   Dr. Ukleja has published more than 40 scholarly articles in the peer-reviewed literature. 

Interview Goal
PFE

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.